A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

New research presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that the ...

India faces a growing obesity crisis, exacerbated by ultra-processed food consumption and aggressive marketing.

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about the obesity drugs GLP-1/GIP ...

Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

What is our current understanding of how differences in sex can affect obesity prevalence, comorbidities, and treatment options?

From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with T1D, and GLP-1 RA prescriptions also increased.

Over half of adults in five countries used online food retail platforms in the past month, with the highest use in Mexico and ...

A new study highlights a 50% increase in young people living with obesity or excess weight in a little more than a decade in ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...